# DUVYZAT™ (givinostat) — Official Patient Website

> Information and resources for patients and caregivers about DUVYZAT (givinostat), a prescription treatment for Duchenne muscular dystrophy (DMD) in people 6 years of age and older.

**Important notes**
- Canonical domain(s): https://www.duvyzat.com
- Ownership: ITF Therapeutics (DUVYZAT is a registered trademark of Italfarmaco S.p.A.)
- Content scope: U.S. patient/caregiver information; HCP resources available on a separate site.
- Update cadence: Site updated periodically; see page footers for content codes and dates.
- Preferred citation: “DUVYZAT™ (givinostat) — Official Patient Website, accessed YYYY-MM-DD.”

## Start here
- [Home](https://www.duvyzat.com/): Overview of indication, key safety, and how DUVYZAT may help.
- [How It Works](https://www.duvyzat.com/why-duvyzat/how-it-works/): HDAC-inhibition concept and why DUVYZAT works differently.
- [How DUVYZAT May Help](https://www.duvyzat.com/why-duvyzat/how-duvyzat-may-help/): Trial overview and outcomes highlights.

## Taking DUVYZAT
- [Dosing & Monitoring](https://www.duvyzat.com/taking-duvyzat/dosing-monitoring/): Daily routine guidance and required monitoring.
- [Safety Information](https://www.duvyzat.com/taking-duvyzat/safety-information/): Key risks, common AEs, and when to contact a provider.

## Support & Resources
- [Patient Support (ITF ARC)](https://www.duvyzat.com/support-resources/patient-support/): Access, resources, and care enrollment support.
- [Downloads & FAQs](https://www.duvyzat.com/support-resources/downloads-faqs/): Tools, the discussion guide, and common questions.
- [Support Organizations](https://www.duvyzat.com/support-resources/support-organizations/): Community and advocacy links.

## Disease Education
- [About Duchenne](https://www.duvyzat.com/about-duchenne/): Condition basics for patients and caregivers.
- [Real Stories](https://www.duvyzat.com/real-stories/): Patient experiences with DUVYZAT.

## Prescribing & Labeling (authoritative)
- [Full Prescribing Information (PI)](https://www.itftherapeutics.com/pi/duvyzat): FDA-approved labeling (external).
- [Medication Guide](https://www.itftherapeutics.com/medguide/duvyzat): FDA-approved patient Med Guide (external).
- [FDA Label (PDF)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217865Orig1s000lbl.pdf): Official label PDF including Warnings & Precautions (external).

## Data & Structure
- [Sitemap](https://www.duvyzat.com/sitemap/): Full navigation list for URL discovery.
- Structured data: Pages may include standard HTML content suitable for extraction; no separate schema catalog is published on the patient site.

## Contact & Policies
- [Contact](https://www.itftherapeutics.com/contact/): ITF Therapeutics contact (external).
- [Privacy Policy](https://itftherapeutics.com/privacy-policy/): Privacy policy (external).
- [Terms of Use](https://www.italfarmaco.com/en/terms-and-conditions): Terms (external).

## Optional
- [For Healthcare Providers](https://www.duvyzathcp.com/): HCP site with clinical data and MOA (external).
- [En español](https://www.duvyzat.com/es/): Spanish entry point (if available on your deployment).